In NOMO-1 siRNA-mediated knockdown of NANOG resulted in reduced expression of MIR17HG (Fig 8G), demonstrating that its reported potential to transactivate this anti-apoptosis factor operated in AML as well [48]. This evidence concerns the gene NOMO1 and acute myeloid leukemia.